These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19883590)

  • 1. Helical conformation of the SEVI precursor peptide PAP248-286, a dramatic enhancer of HIV infectivity, promotes lipid aggregation and fusion.
    Brender JR; Hartman K; Gottler LM; Cavitt ME; Youngstrom DW; Ramamoorthy A
    Biophys J; 2009 Nov; 97(9):2474-83. PubMed ID: 19883590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR structure in a membrane environment reveals putative amyloidogenic regions of the SEVI precursor peptide PAP(248-286).
    Nanga RP; Brender JR; Vivekanandan S; Popovych N; Ramamoorthy A
    J Am Chem Soc; 2009 Dec; 131(49):17972-9. PubMed ID: 19995078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semen-derived amyloidogenic peptides-Key players of HIV infection.
    Lee YH; Ramamoorthy A
    Protein Sci; 2018 Jul; 27(7):1151-1165. PubMed ID: 29493036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amyloidogenic SEVI precursor, PAP248-286, is highly unfolded in solution despite an underlying helical tendency.
    Brender JR; Nanga RP; Popovych N; Soong R; Macdonald PM; Ramamoorthy A
    Biochim Biophys Acta; 2011 Apr; 1808(4):1161-9. PubMed ID: 21262195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SEVI, the semen enhancer of HIV infection along with fragments from its central region, form amyloid fibrils that are toxic to neuronal cells.
    Elias AK; Scanlon D; Musgrave IF; Carver JA
    Biochim Biophys Acta; 2014 Sep; 1844(9):1591-8. PubMed ID: 24948476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infection.
    Tan S; Lu L; Li L; Liu J; Oksov Y; Lu H; Jiang S; Liu S
    PLoS One; 2013; 8(3):e59777. PubMed ID: 23544097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myricetin antagonizes semen-derived enhancer of viral infection (SEVI) formation and influences its infection-enhancing activity.
    Ren R; Yin S; Lai B; Ma L; Wen J; Zhang X; Lai F; Liu S; Li L
    Retrovirology; 2018 Jul; 15(1):49. PubMed ID: 30012153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Semen-derived enhancer of viral infection--a key factor in sexual transmission of HIV].
    Duan JM; Qiu JY; Tan SY; Liu SW; Li L
    Bing Du Xue Bao; 2012 Jan; 28(1):84-8. PubMed ID: 22416356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of HIV-1 infectivity by simple, self-assembling modular peptides.
    Easterhoff D; DiMaio JT; Doran TM; Dewhurst S; Nilsson BL
    Biophys J; 2011 Mar; 100(5):1325-34. PubMed ID: 21354406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site specific interaction of the polyphenol EGCG with the SEVI amyloid precursor peptide PAP(248-286).
    Popovych N; Brender JR; Soong R; Vivekanandan S; Hartman K; Basrur V; Macdonald PM; Ramamoorthy A
    J Phys Chem B; 2012 Mar; 116(11):3650-8. PubMed ID: 22360607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the Influence of Semen-Derived Enhancer of Virus Infection on the Interaction of HIV-1 with Female Reproductive Tract Tissues.
    Allen SA; Carias AM; Anderson MR; Okocha EA; Benning L; McRaven MD; Kelley ZL; Lurain J; Veazey RS; Hope TJ
    J Virol; 2015 May; 89(10):5569-80. PubMed ID: 25740984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI.
    Kim KA; Yolamanova M; Zirafi O; Roan NR; Staendker L; Forssmann WG; Burgener A; Dejucq-Rainsford N; Hahn BH; Shaw GM; Greene WC; Kirchhoff F; Münch J
    Retrovirology; 2010 Jun; 7():55. PubMed ID: 20573198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection.
    Roan NR; Münch J; Arhel N; Mothes W; Neidleman J; Kobayashi A; Smith-McCune K; Kirchhoff F; Greene WC
    J Virol; 2009 Jan; 83(1):73-80. PubMed ID: 18945786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties and structures of the influenza and HIV fusion peptides on lipid membranes: implications for a role in fusion.
    Haque ME; Koppaka V; Axelsen PH; Lentz BR
    Biophys J; 2005 Nov; 89(5):3183-94. PubMed ID: 16183890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection).
    Roan NR; Sowinski S; Münch J; Kirchhoff F; Greene WC
    J Biol Chem; 2010 Jan; 285(3):1861-9. PubMed ID: 19897482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seminal plasma accelerates semen-derived enhancer of viral infection (SEVI) fibril formation by the prostatic acid phosphatase (PAP248-286) peptide.
    Olsen JS; DiMaio JT; Doran TM; Brown C; Nilsson BL; Dewhurst S
    J Biol Chem; 2012 Apr; 287(15):11842-9. PubMed ID: 22354963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The helix-to-sheet transition of an HIV-1 fusion peptide derivative changes the mechanical properties of lipid bilayer membranes.
    Heller WT; Zolnierczuk PA
    Biochim Biophys Acta Biomembr; 2019 Mar; 1861(3):565-572. PubMed ID: 30550881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of fusion peptides from HIV gp41 with membranes: a time-resolved membrane binding, lipid mixing, and structural study.
    Buzón V; Padrós E; Cladera J
    Biochemistry; 2005 Oct; 44(40):13354-64. PubMed ID: 16201760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fully hydrophobic HIV gp41 adopts a hemifusion-like conformation in phospholipid bilayers.
    Lee M; Morgan CA; Hong M
    J Biol Chem; 2019 Oct; 294(40):14732-14744. PubMed ID: 31409642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The polar region consecutive to the HIV fusion peptide participates in membrane fusion.
    Peisajovich SG; Epand RF; Pritsker M; Shai Y; Epand RM
    Biochemistry; 2000 Feb; 39(7):1826-33. PubMed ID: 10677233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.